BIOTIME Aktie

3,32 EUR 1,2828%

Zu Ihrem Onlinebroker

kaufen verkaufen

BIOTIME Aktienkurs : 08:08 ( 15 Min. verzögert)
3,32 € Letzter Kurs	1,28% Veränderung	3,27 € Vortag	3,32 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
3,32 - 3,32 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	2 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

BIOTIME Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

“Where's the beef”, OSIR recaptures gain as sector wavers

Minimal downward moves: Advanced Cell Technology (OTC BB: ACTC), BioTime (Amex: BTX), Brainstorm (OTC BB: BCLI), Dendreon (DNDN), Pluristem (PSTI), Tengion (TNGN), Cytomedix (OTC BB: CMXI), Fibrocell (OTC BB: FCSC),...
23.05.

US FDA Staff Shoot Down Pfizer Rare Disease Drug; Repros Updates Special ...

BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research and Development Company Ltd, the technology transfer a…

23.05.

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards ...

XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012. The new release is available...
23.05.

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards(R ...

CAMBRIDGE, Mass., May 23, 2012 (BUSINESS WIRE) -- XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (nyse amex:BTX), announced today the release of GeneCards(R), Version 3.08, on May 20, 2012. The new release is available...
22.05.

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market ...

ALAMEDA, Calif., May 22, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research...